4//SEC Filing
BHATIA NAVEEN 4
Accession 0000899243-21-036569
CIK 0000948320other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 2:29 PM ET
Size
14.2 KB
Accession
0000899243-21-036569
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
BHATIA NAVEEN
Director
Transactions
- Exercise of In-Money
Common Stock
2021-09-15$1.75/sh+96,349$168,611→ 96,349 total - Award
Stock Option (Right to Buy)
2021-09-08+100,000→ 100,000 totalExercise: $7.07From: 2021-09-08Exp: 2021-09-08→ Common Stock (100,000 underlying) - Award
Restricted Stock Unit
2021-09-08+8,000→ 8,000 totalExercise: $0.00→ Common Stock (8,000 underlying) - Gift
Warrant (Right to Buy)
2021-09-15+96,349→ 96,349 totalExercise: $1.75From: 2021-09-15Exp: 2022-01-12→ Common Stock (96,349 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2021-09-15−96,349→ 0 totalExercise: $1.75From: 2021-09-15Exp: 2022-01-12→ Common Stock (96,349 underlying)
Footnotes (2)
- [F1]Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 8,000 Restricted Stock Units ("RSUs"), vesting quarterly with 25% vesting on September 30, 2021 and the remaining vesting ratably on December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. The RSUs represent a contingent right to receive one share of Common Stock for each RSU.
- [F2]Mr. Bhatia received an option to purchase 100,000 shares of Common Stock, at an exercise price of $7.07 per share, as compensation for services to be provided pursuant to a Consulting Agreement dated September 8, 2021.
Documents
Issuer
LifeMD, Inc.
CIK 0000948320
Entity typeother
Related Parties
1- filerCIK 0001452171
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 2:29 PM ET
- Size
- 14.2 KB